Business Of Biotech cover image

008: Commitment To GMP With Dr. Shabbir Anik

Business Of Biotech

00:00

The Risks of Outsourcing a Product Development Process

Most companies do have the internal capabilities. CDMOs are willing to work with companies where any proprietary discoveries are passed on back to the company. Alternatively, as I mentioned, you may want to have some internal capabilities specifically focused on the proprietary aspects of what you're developing. And that can be relatively small to manage that while you continue to manage all of the standard development activities.

Play episode from 13:34
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app